Mahesh Karande

Insider Reports History

Entity
Individual
Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mahesh Karande:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 314K Feb 7, 2024 Direct

Insider Reports Filed by Mahesh Karande

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMGA Omega Therapeutics, Inc. Feb 7, 2024 2 $0 4 Feb 9, 2024 President and CEO, Director
OMGA Omega Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 President and CEO, Director
OMGA Omega Therapeutics, Inc. Oct 27, 2022 1 $0 4 Oct 28, 2022 President and CEO, Director
OMGA Omega Therapeutics, Inc. Mar 9, 2022 1 $0 4 Mar 11, 2022 President and CEO, Director
OMGA Omega Therapeutics, Inc. Feb 1, 2022 2 $5.99K 4 Feb 3, 2022 President and CEO, Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 President and CEO, Director, 10%+ Owner